Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-010986
Filing Date
2023-07-10
Accepted
2023-07-10 17:04:36
Documents
2
Period of Report
2023-06-29

Document Format Files

Seq Description Document Type Size
1 form3-07102023_090731.html 3  
1 form3-07102023_090731.xml 3 9858
2 ex24-07102023_090731.htm EX-24 7689
  Complete submission text file 0001415889-23-010986.txt   18847
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Donoghoe Nicholas (Reporting) CIK: 0001762951 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35565 | Film No.: 231080464